Publications by authors named "A Yartsev"

Background: Patients undergoing chimeric antigen receptor (CAR) T-cell therapy are vulnerable to infection and sepsis. Treatment course is frequently complicated by cytokine release syndrome which is often clinically and biochemically indistinguishable from sepsis. Procalcitonin (PCT) levels have been examined as a promising biomarker for infection in this cohort of patients.

View Article and Find Full Text PDF
Article Synopsis
  • Terlipressin can cause bradycardia, typically seen with hypertension, and is generally not monitored in patients receiving it.
  • A case study of a 77-year-old woman with no heart issues developed severe bradycardia and hypotension after receiving terlipressin for cholangitis and variceal bleeding.
  • The study suggests that terlipressin could affect older patients differently, possibly necessitating cardiac monitoring for the elderly, even though such effects aren't commonly highlighted in existing safety literature.
View Article and Find Full Text PDF

We present the extraordinary circumstance of a female patient in her sixties who suffered a massive lignocaine overdose while undergoing treatment with Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO) following an emergency coronary artery bypass graft (CABG). The patient was initially admitted to the Intensive Care Unit (ICU) due to unstable angina and a history of insulin-dependent type two diabetes mellitus, hypertension, hypercholesterolemia, carotid artery stenosis, and an extensive smoking history. Despite initial improvements following surgery, she experienced repeated episodes of nonsustained polymorphic ventricular tachycardia (VT) that were refractory to conventional antiarrhythmic medications.

View Article and Find Full Text PDF

Two iron complexes featuring the bidentate, nonconjugated N-heterocyclic carbene (NHC) 1,1'-methylenebis(3-methylimidazol-2-ylidene) (mbmi) ligand, where the two NHC moieties are separated by a methylene bridge, have been synthesized to exploit the combined influence of geometric and electronic effects on the ground- and excited-state properties of homoleptic Fe-hexa-NHC [Fe(mbmi)](PF) and heteroleptic Fe-tetra-NHC [Fe(mbmi)(bpy)](PF) (bpy = 2,2'-bipyridine) complexes. They are compared to the reported Fe-hexa-NHC [Fe(btz)](PF) and Fe-tetra-NHC [Fe(btz)(bpy)](PF) complexes containing the conjugated, bidentate mesoionic NHC ligand 3,3'-dimethyl-1,1'-bis(-tolyl)-4,4'-bis(1,2,3-triazol-5-ylidene) (btz). The observed geometries of [Fe(mbmi)](PF) and [Fe(mbmi)(bpy)](PF) are evaluated through L-Fe-L bond angles and ligand planarity and compared to those of [Fe(btz)](PF) and [Fe(btz)(bpy)](PF).

View Article and Find Full Text PDF